专利汇可以提供杀虫基因和使用方法专利检索,专利查询,专利分析的服务。并且提供了具有 杀虫活性 的组合物及其使用方法。所述组合物包括具有杀虫活性的分离的和重组的多肽,编码所述多肽的重组和合成的核酸分子,包含所述核酸分子的DNA构建体和载体,包含所述载体的宿主细胞和针对所述多肽的 抗体 。编码所述多肽的核苷酸序列可以用于DNA构建体或表达盒中,用于在目的 生物 中的转化和表达。提供的组合物和方法可用于生产具有增强的 害虫 抗性或耐受性的生物。还提供了包含编码本 发明 的杀虫 蛋白质 的核苷酸序列的转基因 植物 和 种子 。这种植物对昆虫和其他害虫具有抗性。提供了用于产生本文公开的各种多肽以及使用这些多肽控制或杀死害虫的方法。还包括用于检测样品中的本发明多肽的方法和 试剂 盒 。,下面是杀虫基因和使用方法专利的具体信息内容。
1.一种具有杀虫活性的重组多肽,其包含:
(a)包含与选自SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,
20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,
45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,
70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,
95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,
115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,
134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,
153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,
172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,
191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,
210,211,212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,227,
228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,
247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,
266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,
285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,
304,305,306,307,308或309中所示序列的氨基酸序列具有至少90%序列同一性百分比的氨基酸序列的多肽;或者
(b)包含SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,
22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,
47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,
72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,
97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,
117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,
136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,
155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,
174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,
193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,
212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,227,228,229,
230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,
249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,
268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,
287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,
306,307,308或309中所示的氨基酸序列的多肽。
2.权利要求1的多肽,所述多肽进一步包含异源氨基酸序列。
3.一种组合物,其包含权利要求1或2的多肽。
4.一种编码氨基酸序列的重组核酸分子,所述氨基酸序列包含:
(a)与选自SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,
22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,
47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,
72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,
97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,
117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,
136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,
155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,
174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,
193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,
212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,227,228,229,
230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,
249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,
268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,
287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,
306,307,308或309中所示序列的氨基酸序列具有至少90%的序列同一性百分比;或者(b)SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,
24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,
49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,
74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,
99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,
118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,
137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,
156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,
175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,
194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,
213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,227,228,229,230,
231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,
250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,
269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,
288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,
307,308或309中所示的氨基酸序列;
其中所述重组核酸分子并非编码所述多肽的天然存在的序列。
5.权利要求4的重组核酸分子,其中所述重组核酸分子是设计用于在植物中表达的合成序列。
6.权利要求4或5的重组核酸分子,其中所述重组核酸分子与能够指导在植物细胞中的表达的启动子可操作地连接。
7.权利要求4-6中任一项的重组核酸分子,其中所述重组核酸分子与能够指导在细菌中的表达的启动子可操作地连接。
8.一种宿主细胞,其包含权利要求4-7中任一项的重组核酸分子。
9.权利要求8的宿主细胞,其中所述宿主细胞是细菌宿主细胞。
10.一种DNA构建体,其包含驱动植物细胞中的表达的启动子,所述启动子可操作地连接至重组核酸分子,所述重组核酸分子包含编码多肽的核苷酸序列,所述多肽包含与选自SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,
26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,
51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,
76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,
101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,
120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,
139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,
158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,
177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,
196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,
215,216,217,218,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,
233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,
252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,
271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,
290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,307,308或
309中所示的序列的氨基酸序列具有至少90%序列同一性百分比的氨基酸序列。
11.权利要求10的DNA构建体,其中所述核苷酸序列是设计用于在植物中表达的合成DNA序列。
12.一种载体,其包含权利要求10或11的DNA构建体。
13.一种宿主细胞,其包含权利要求10或11的DNA构建体或者权利要求12的载体。
14.一种组合物,其包含权利要求8、9或13的宿主细胞。
15.权利要求14的组合物,其中所述组合物选自粉末、粉剂、丸剂、颗粒剂、喷雾剂、乳剂、胶体和溶液。
16.权利要求14或15的组合物,其中所述组合物按重量计包含约1%至约99%的所述多肽。
17.一种用于控制害虫群体的方法,其包括使所述害虫群体与杀虫有效量的权利要求3或14-16中任一项的组合物接触。
18.一种用于产生具有杀虫活性的多肽的方法,其包括在其中编码所述多肽的核酸分子被表达的条件下,培养权利要求8、9或13中任一项的宿主细胞。
19.一种具有稳定整合到其基因组内的DNA构建体的植物,所述DNA构建体包含编码具有杀虫活性的蛋白质的核苷酸序列,其中所述核苷酸序列包含:
(a)编码包含SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,
21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,
46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,
71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,
96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,
116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,
135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,
154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,
173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,
192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,
211,212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,227,228,
229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,
248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,
267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,
286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,
305,306,307,308或309中任何一个的氨基酸序列的多肽的核苷酸序列;或者(b)编码包含与选自SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,
19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,
44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,
69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,
94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,
114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,
133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,
152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,
171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,
190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,
209,210,211,212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,
227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,
246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,
265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,
284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,
303,304,305,306,307,308或309中所示序列的氨基酸序列具有至少90%序列同一性百分比的氨基酸序列的多肽的核苷酸序列。
20.权利要求19的植物的转基因种子。
21.一种用于保护植物免受昆虫害虫的方法,其包括在植物或其细胞中表达编码杀虫多肽的核苷酸序列,其中所述核苷酸序列包含:
(a)编码包含SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,
21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,
46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,
71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,
96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,
116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,
135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,
154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,
173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,
192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,
211,212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,227,228,
229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,
248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,
267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,
286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,
305,306,307,308或309中任何一个的氨基酸序列的多肽的核苷酸序列;或者(b)编码包含与选自SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,
19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,
44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,
69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,
94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,
114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,
133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,
152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,
171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,
190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,
209,210,211,212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,
227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,
246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,
265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,
284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,
303,304,305,306,307,308或309中所示序列的氨基酸序列具有至少90%序列同一性百分比的氨基酸序列的多肽的核苷酸序列。
22.权利要求21的方法,其中所述植物产生针对鳞翅目害虫、鞘翅目害虫或半翅目害虫中的至少一种具有杀虫活性的杀虫多肽。
23.一种用于增加植物产量的方法,其包括在田间生长具有稳定整合到其基因组内的DNA构建体的植物或其种子,所述DNA构建体包含可操作地连接至编码杀虫多肽的核苷酸序列的启动子,所述启动子驱动在植物中的表达,其中所述核苷酸序列包含:
(a)编码包含SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,
21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,
46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,
71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,
96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,
116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,
135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,
154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,
173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,
192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,
211,212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,227,228,
229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,
248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,
267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,
286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,
305,306,307,308或309中任何一个的氨基酸序列的多肽的核苷酸序列;或者(b)编码包含与选自SEQ ID NO:1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,
19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,
44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,
69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,
94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,
114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,
133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,
152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,
171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,
190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,
209,210,211,212,213,214,215,216,217,218,218,219,220,221,222,223,224,225,226,
227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,
246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,
265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,
284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,
303,304,305,306,307,308或309中所示序列的氨基酸序列具有至少90%序列同一性百分比的氨基酸序列的多肽的核苷酸序列。
标题 | 发布/更新时间 | 阅读量 |
---|---|---|
一种斑马鱼肾脏祖细胞标记转基因系的构建方法 | 2020-05-13 | 187 |
一种用于治疗肿瘤的基因重组造血干细胞及其制备方法 | 2020-05-13 | 508 |
乳腺特异性表达抗菌肽Cecropin基因的同源重组载体及应用 | 2020-05-13 | 979 |
心脏干细胞 | 2020-05-12 | 405 |
通过异种间的核移植产生的胚细胞或干细胞样细胞系 | 2020-05-11 | 512 |
一种建立大肠癌p73报告基因细胞系的方法 | 2020-05-11 | 349 |
通过交叉物种核移植制备的胚胎或干样细胞系及通过遗传改变供体细胞或通过组织培养条件增强胚胎发育的方法 | 2020-05-11 | 841 |
异源基因的表达方法及其所用的媒介物 | 2020-05-11 | 304 |
一种利用家畜乳腺高效生产人溶菌酶的方法 | 2020-05-13 | 437 |
一种演示细胞分裂的教学模型 | 2020-05-11 | 503 |
高效检索全球专利专利汇是专利免费检索,专利查询,专利分析-国家发明专利查询检索分析平台,是提供专利分析,专利查询,专利检索等数据服务功能的知识产权数据服务商。
我们的产品包含105个国家的1.26亿组数据,免费查、免费专利分析。
专利汇分析报告产品可以对行业情报数据进行梳理分析,涉及维度包括行业专利基本状况分析、地域分析、技术分析、发明人分析、申请人分析、专利权人分析、失效分析、核心专利分析、法律分析、研发重点分析、企业专利处境分析、技术处境分析、专利寿命分析、企业定位分析、引证分析等超过60个分析角度,系统通过AI智能系统对图表进行解读,只需1分钟,一键生成行业专利分析报告。